Zacks Investment Research
10 Feb 2026, 15:40 UTC · 34w ago
Verdict
Headline takes no side. We score BHVN +0.80 — strongly bullish.
+0.80strongly bullish
More positive than 87% of ticker scores this week
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
Which stocks this story touches
More positive than 87% of ticker scores this week
The company has a Zacks Rank of #2 (Buy), outperforming its sector and industry with improving earnings estimates.
More positive than 75% of ticker scores this week
The company has a Zacks Rank of #2 (Buy) and has outperformed its sector year-to-date.
Continue reading
5 related stories
More positive than 14% of relationship scores this week
[mutual] Both companies are identified as peers within the Medical - Biomedical and Genetics industry.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Proactive Investors
2h ago
−5.5%
Price is moving against the score
$12.08 vs $12.78 close before publication (Feb 9) · not market-adjusted
BHVN chart →
